Christoph U. Correll, MD
Department of Psychiatry, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, New York; Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York; Department of Child and Adolescent Psychiatry, Charité–Universitätsmedizin Berlin, Berlin, Germany; German Center for Mental Health (DZPG), Partner Site Berlin, Berlin, Germany
Insight videos
Patient Functioning and Life Engagement: Unmet Needs in MDD and Schizophrenia
August 8, 2022
Besides achieving symptom relief and improved functioning, many patients with serious mental illness wish to connect more with others and feel engaged with their lives. Five experts discuss life...
Academic Highlights
Patient Functioning and Life Engagement: Unmet Needs in MDD and Schizophrenia
August 3, 2022
Besides achieving symptom relief and improved functioning, many patients with serious mental illness wish to connect more with others and feel engaged with their lives. Five experts discuss life...
Review Article
Outcomes of NMS With Depot Versus Oral Antipsychotics
November 24, 2020
Is the advantage of longer-term medication release with long-acting injectable antipsychotics offset by an increased risk of more prolonged and severe neuroleptic malignant syndrome? This systematic review and pooled...
Academic Highlights
Schizophrenia Remission Roller Coaster
June 30, 2020
In this journal CME activity, find experts' recommendations for reducing schizophrenia relapse, such as adopting a patient-centered approach, selecting medications based on current evidence, and implementing psychosocial interventions.
